Export 325 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is H  [Clear All Filters]
2017
Rynkevic, R., Martins, P., Hympanova, L., Almeida, H., et al. (2017). Biomechanical and morphological properties of the multiparous ovine vagina and effect of subsequent pregnancy. Journal of Biomechanics, 57, 94 - 102.
Morais, M. A. B., Giuseppe, P. O., Souza, T. A. C. B., Castro, H., et al. (2017). Calcium and magnesium ions modulate the oligomeric state and function of mitochondrial 2-Cys peroxiredoxins in Leishmania parasites. Journal of Biological Chemistry, 292(17), 7023 - 7039.
Borry, P., Bentzen, H. B., Budin-Ljøsne, I., Cornel, M. C., et al. (2017). The challenges of the expanded availability of genomic information: an agenda-setting paper. Journal of Community Genetics.
Chapple, C. R., Cruz, F., Deffieux, X., Milani, A. L., et al. (2017). Consensus Statement of the European Urology Association and the European Urogynaecological Association on the Use of Implanted Materials for Treating Pelvic Organ Prolapse and Stress Urinary Incontinence. European Urology, 72(3), 424 - 431.
McCarthy, R. R., Mazon-Moya, M. J., Moscoso, J. A., Hao, Y., et al. (2017). Cyclic-di-GMP regulates lipopolysaccharide modification and contributes to Pseudomonas aeruginosa immune evasion. Nature Microbiology, 2.
Middleton, A., Mendes, A., Benjamin, C. M., & Howard, H. C. (2017). Direct-to-consumer genetic testing: Where and how does genetic counseling fit?. Personalized Medicine, 14(3), 249 - 257.
Nissinen, J., Andrade, P., Natunen, T., Hiltunen, M., et al. (2017). Disease-modifying effect of atipamezole in a model of post-traumatic epilepsy. Epilepsy Research, 136, 18 - 34.
Piovesan, D., Tabaro, F., Mičetić, I., Necci, M., et al. (2017). DisProt 7.0: A major update of the database of disordered proteins. Nucleic Acids Research, 45(D1), D219 - D227.
Kennelly, M., Dmochowski, R., Schulte-Baukloh, H., Ethans, K., et al. (2017). Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study. Neurourology and Urodynamics, 36(2), 368 - 375.
Kennelly, M., Dmochowski, R., Schulte-Baukloh, H., Ethans, K., et al. (2017). Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study. Neurourology and Urodynamics, 36(2), 368 - 375.
Kennelly, M., Dmochowski, R., Schulte-Baukloh, H., Ethans, K., et al. (2017). Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study. Neurourology and Urodynamics, 36(2), 368 - 375.
Kennelly, M., Dmochowski, R., Schulte-Baukloh, H., Ethans, K., et al. (2017). Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study. Neurourology and Urodynamics, 36(2), 368 - 375.
Kennelly, M., Dmochowski, R., Schulte-Baukloh, H., Ethans, K., et al. (2017). Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study. Neurourology and Urodynamics, 36(2), 368 - 375.
Kennelly, M., Dmochowski, R., Schulte-Baukloh, H., Ethans, K., et al. (2017). Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study. Neurourology and Urodynamics, 36(2), 368 - 375.
Kennelly, M., Dmochowski, R., Schulte-Baukloh, H., Ethans, K., et al. (2017). Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study. Neurourology and Urodynamics, 36(2), 368 - 375.
Kennelly, M., Dmochowski, R., Schulte-Baukloh, H., Ethans, K., et al. (2017). Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study. Neurourology and Urodynamics, 36(2), 368 - 375.
Höhn, A., Weber, D., Jung, T., Ott, C., et al. (2017). Happily (n)ever after: Aging in the context of oxidative stress, proteostasis loss and cellular senescence. Redox Biology, 11, 482 - 501.
Höhn, A., Weber, D., Jung, T., Ott, C., et al. (2017). Happily (n)ever after: Aging in the context of oxidative stress, proteostasis loss and cellular senescence. Redox Biology, 11, 482 - 501.
Afshin, A., Forouzanfar, M. H., Reitsma, M. B., Sur, P., et al. (2017). Health effects of overweight and obesity in 195 countries over 25 years. New England Journal of Medicine, 377(1), 13 - 27.
Afshin, A., Forouzanfar, M. H., Reitsma, M. B., Sur, P., et al. (2017). Health effects of overweight and obesity in 195 countries over 25 years. New England Journal of Medicine, 377(1), 13 - 27.
Afshin, A., Forouzanfar, M. H., Reitsma, M. B., Sur, P., et al. (2017). Health effects of overweight and obesity in 195 countries over 25 years. New England Journal of Medicine, 377(1), 13 - 27.
Afshin, A., Forouzanfar, M. H., Reitsma, M. B., Sur, P., et al. (2017). Health effects of overweight and obesity in 195 countries over 25 years. New England Journal of Medicine, 377(1), 13 - 27.
Afshin, A., Forouzanfar, M. H., Reitsma, M. B., Sur, P., et al. (2017). Health effects of overweight and obesity in 195 countries over 25 years. New England Journal of Medicine, 377(1), 13 - 27.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@i3s.up.pt | © copyright 2010 ibmc